|
QuintilesIMS Real-World Insights Bibliography
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
 |
| |
| |
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. |
| Author(s): Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. |
| Affiliations(s): 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
2Department of Rheumatology, CHU Strasbourg, Strasbourg, France.
3University of Cologne, Cologne, Germany.
4L Sacco University Hospital, Milan, Italy.
5University of Montreal, Montreal, Canada.
6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico.
8Department of Rheumatology, University of Liverpool, Liverpool, UK.
9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
10Hellenic Foundation for Rheumatological Research, Athens, Greece.
11Quintiles, Rockville, Maryland, USA.
12F Hoffmann-La Roche Ltd, Basel, Switzerland.
13Genentech Inc, San Francisco, California, USA.
14University Hospital of Geneva, Geneva, Switzerland. |
| Publication(s): Ann Rheum Dis. 2015 Jun;74(6):979-84 |
| Document Type(s): Article |
| Countries: Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Rheumatology
2015 |
|
L:
A: |
English
Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Norway |
| Author(s): Troelsgaard A1, Huetson P2, Kjellberg J3, Hemels M1, Knudsen M4
|
| Affiliations(s): Janssen A/S, Birkerød, Denmark, 2IMS Health, Stockholm, Sweden, 3Zefferin Farma AB, Stockholm, Sweden, 4IMS Health, Hellerup, Denmark |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: Norway |
C:
Y: |
Diabetes
2014 |
|
L:
A: |
English
Economic evaluation |
|
|
| |
| |
| Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. |
| Author(s): Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7,
Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10,
Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2 |
| Affiliations(s): 1
Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2
CIBER of
Epidemiology and Public Health, Madrid, Spain; 3
Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4
Department of Epidemiology, Johns Hopkins Bloomberg School
of Public Health, Baltimore, MD 21205, USA; 5
Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6
Welch Center for
Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7
Department of Cardiovascular Epidemiology and
Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8
Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN,
UK; 9
Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003
Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium |
| Publication(s): Eur Heart J. 2011 Sep;32(17):2143-52 |
| Document Type(s): Article |
| Countries: Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2011 |
|
L:
A: |
English
Observational study, Prospective study |
|
|
| |
| |
| Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. |
| Author(s): Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F. |
| Affiliations(s): |
| Publication(s): BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704. |
| Document Type(s): Article |
| Countries: Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2011 |
|
L:
A: |
English
Observational study, Prospective study |
|
|
| |
| |
| Continuous subcutaneous insulin infusions versus multiple daily injection of insulin in patients with type 1 diabetes: a long-term health economic analysis in the Norwegian and Swedish settings |
| Author(s): Goodall G1, Nicklasson L2, Zakrzewska K3, Foos V1,Valentine WJ1,Roze S1, Palmer AJ1 |
| Affiliations(s):
CORE—Center for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Medtronic AB, Järfälla, Sweden, 3 Medtronic AG, Tolochenaz, Switzerland |
Publication(s):
Value in Health, 2006:9 (6) A227 |
| Document Type(s): Poster |
| Countries: Norway, Sweden |
C:
Y: |
Diabetes
2006 |
|
L:
A: |
English
Economic evaluation |
|
|
| |
| |
|
|
|
